Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1272 (MIR1272) is a small, non-coding RNA molecule in humans that regulates gene expression primarily by binding to sequences in the 3′ untranslated regions (3′ UTRs) of messenger RNAs. Like other microRNAs, it guides the RNA-induced silencing complex (RISC) to its mRNA targets, resulting in translational repression or mRNA degradation. MIR1272 is transcribed as a primary miRNA (pri-miRNA) and processed through the canonical microRNA biogenesis pathway involving proteins such as Drosha and Dicer before becoming a mature miRNA[1][4]. The specific biological targets and functions of MIR1272 remain incompletely characterized in the scientific literature as of the current date.
Post-transcriptional gene silencing, mRNA degradation, Translational repression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1272 (MIR1272).